Travel Vaccines Market research study 2023-2028 enhances the decision-making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at the insight partners. Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status

An exclusive Travel Vaccines Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

According to our latest research study, titled “Global Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product and Application,” the market is expected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021. It is estimated to grow at a CAGR of 9.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing its growth. The rapid growth of the travel and tourism sector, prevention of transnational infections, and the rising incidence of infectious diseases contribute to the market’s progress. However, the high cost of travel vaccines hinders the market’s growth.

Based on product, the travel vaccines market is segmented into hepatitis A, hepatitis B, meningococcal vaccines, diphtheria pertussis tetanus (DPT), yellow fever, typhoid, Japanese encephalitis, measles mumps & rubella, rabies, polio, influenza, varicella & shingles, cholera, and others. The hepatitis A segment is expected to account for the largest market share during the period of 2021–2028, while the DPT segment is expected to have the most significant growth over the forecast period, adding to the travel vaccines market size.


The prominent/emerging players in the Travel Vaccines Market research include:

  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi
  • Novartis AG
  • Pfizer Inc.
  • Dynavax Technologies
  • Emergent BioSolutions Inc.
  • Abbott
  • Bharat Biotech
  • Valneva SE.

Based on application, the travel vaccines market is segmented into domestic travel and outbound travel. The outbound travel segment held the leading share of the market in 2021. It is likely to continue its dominance over the market during the forecast period. The same segment is expected to have the highest CAGR during the forecast period as well.

During the pre-pandemic era, the status of travelers getting the travel vaccine was The COVID-19 pandemic has had a significant impact on the global health economies and has significantly pressurized the healthcare infrastructure across the world. As major healthcare infrastructures were focused on treating COVID-19 patients, significant restrictions were imposed on domestic and international travel.


About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
Phone: +1-646-491-9876